Table 7.
Multi-drug resistance nature of S. aureus isolates at Yekatit 12 Hospital Medical College from September 2013 to April 2014, Addis Ababa, Ethiopia
| Antibiotics | Resistant strains | |
|---|---|---|
| N | % | |
| P, E, SXT | 18 | 18.40 |
| P, G, E | 5 | 5.10 |
| P, C, SXT | 4 | 4.08 |
| P, C, CIP | 3 | 3.06 |
| P, CIP, E, SXT | 13 | 13.26 |
| P, G, C, E | 3 | 3.06 |
| P, G, C, SXT | 2 | 2.04 |
| P, CIP, E, SXT | 1 | 1.02 |
| P, AMC, E, SXT | 1 | 1.02 |
| P, FOX, G, SXT | 1 | 1.02 |
| P, FOX, E, SXT | 2 | 2.04 |
| P, C, CIP, E, SXT | 2 | 2.04 |
| P, G, CIP, AMC, SXT | 1 | 1.02 |
| P, G, CIP, E, SXT | 1 | 1.02 |
| P, G, C, E, SXT | 1 | 1.02 |
| P, CIP, E, SXT, DA | 2 | 2.04 |
| P, FOX, C, E, SXT | 1 | 1.02 |
| P, G, C, CIP, CXM, SXT | 1 | 1.02 |
| P, G, C, CIP, E, SXT | 3 | 3.06 |
| P, G, C, AMC, E, SXT | 1 | 1.02 |
| P, FOX, CIP, E, SXT, DA | 3 | 3.06 |
| P, FOX, C, E, CXM, SXT | 2 | 2.04 |
| P, G, C, CIP, E, SXT, DA | 2 | 2.04 |
| P, FOX, G, C, CIP, E, SXT | 2 | 2.04 |
| P, FOX, C, CIP, E, CXM, SXT | 5 | 5.10 |
| P, FOX, C, E, CXM, SXT, DA | 1 | 1.02 |
| P, FOX, CIP, AMC, KF, E, CXM | 2 | 2.04 |
| P, FOX, CIP, AMC, KF, SXT, DA | 2 | 2.04 |
| P, FOX, G, C, CIP, E, CXM, SXT | 2 | 2.04 |
| P, FOX, VAN, CIP,AMC, E, SXT, DA | 5 | 5.10 |
| P, FOX, VAN, CIP, AMC, E, CXM, SXT, DA | 1 | 1.02 |
| P, FOX, C, CIP, AMC, E, CXM, SXT, DA | 1 | 1.02 |
| P, FOX, VAN, CIP, AMC, KF, E, SXT, DA | 1 | 1.02 |
| P, FOX, VAN, G, C, CIP, AMC, E, SXT, DA | 1 | 1.02 |
| P, FOX, VAN, G, C, CIP, AMC, E, CXM, SXT, DA | 2 | 2.04 |
| Total | 98 | 100.00 |
P Penicillin G, CIP Ciprofloxacin, AMC Amoxicillin-clavulanic acid, C Chloramphenicol, FOX Cefoxitin, KF Cephalothin, E Erythromycin, G Gentamycin, VAN Vancomycin, SXT Trimethoprim-sulphamethoxazole, DA Clindamycin, CXM Cefuroxime